Ovarian Cancer Trial, Recruiting NCT06378905 Sponsor: Cukurova University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06378905
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older.
  • People whose scans suggest advanced cancer of the ovaries, fallopian tubes, or the lining of the abdomen (called primary peritoneal cancer).
  • People who have been confirmed by laboratory testing to have Stage III or Stage IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
  • People who have agreed to take part in the study.

Who may not be able to join:

  • People with an earlier stage (Stage I or Stage II) of epithelial ovarian, fallopian tube, or peritoneal cancer.
  • People whose ovarian cancer is a non-epithelial type (a different cell type of ovarian cancer).
  • People who have a non-cancerous (benign) ovarian tumour.
  • People who have a borderline ovarian tumour (a tumour that is not clearly benign or cancerous).
  • People whose ovarian cancer has spread from another part of the body (metastatic ovarian tumours).
  • People who do not wish to participate in the study.
  • People under 18 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +903223386060

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cukurova University
Registry
ClinicalTrials.gov
Start date
30 May 2024
Est. completion
1 March 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Rate of complete cytoreduction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov